Johnson & Johnson, blaming some of its problems on the closed McNeil Consumer Healthcare facility in Fort Washington, reported a 6.3 percent drop in profits for the third quarter compared with the same period in 2010.
Company officials said in a news release and a conference call with Wall Street analysts that domestic sales and revenue were again hurt in part by the extra costs and lack of income from over-the-counter medicines that had been produced at the plant in Fort Washington. Reporters were not allowed to ask questions in the conference call.
"Sales in U.S. over-the-counter medicines were significantly impacted by the suspension of manufacturing at the McNeil Consumer Healthcare facility in Fort Washington, Pa., as well as the impact on production volumes related to ongoing efforts to enhance quality and manufacturing systems," the company said in a statement.
